---
layout: default
title: Antibody & Protein Production – Vaxonyx
description: Tailored protein and antibody production using mammalian, insect, yeast, and E. coli systems for high yield, purity, and rapid turnaround.
---

<style>
  :root{
    --vx-primary:#007C91;
    --vx-accent:#3FA9F5;
    --vx-ink:#0b1220;
    --vx-line:rgba(12,18,32,.12);
    --vx-bg:conic-gradient(from 210deg at 30% -10%,rgba(0,124,145,.10),rgba(63,169,245,.12),transparent 50%);
  }
  .container{width:min(1120px,92%);margin-inline:auto}
  .svc-hero{padding:88px 0 42px;background:var(--vx-bg)}
  .svc-hero h1{font:800 clamp(30px,4.8vw,54px)/1.1 system-ui;color:var(--vx-ink);margin:0 0 10px}
  .svc-hero p{font:400 16px/1.65 system-ui;color:#213;max-width:70ch;margin:0}
  h2.svc-h2{font:700 clamp(20px,2.6vw,28px)/1.2 system-ui;margin:34px 0 14px;color:var(--vx-ink)}
  ul{margin:8px 0 0 20px;padding:0}
  li{font:400 15px/1.6 system-ui;color:#2a3040}
</style>

<main class="page-services">
  <section class="svc-hero">
    <div class="container">
      <h1>Antibody &amp; Protein Production</h1>
      <p>Excelling in both protein expression and purification, we offer tailored solutions for protein production using mammalian, insect, and <i>E. coli</i> expression platforms, designed to meet diverse and evolving research needs.</p>
    </div>
  </section>

  <section class="container">
    <h2 class="svc-h2">Key Features</h2>
    <ul>
      <li><strong>High-Titer Expression:</strong> Harnessing the latest advancements in biotechnology, our protein production processes ensure high expression levels.</li>
      <li><strong>Rapid Turnaround:</strong> Our streamlined operational processes enable delivery within 4–6 weeks.</li>
      <li><strong>Economical Solutions:</strong> High-titer expression reduces volume and time, yielding cost-effective production.</li>
    </ul>
  </section>

  <section class="container">
    <h2 class="svc-h2">Process of Protein Production</h2>
    <p>Protein production, including expression and purification, is the biotechnical generation of specific proteins using recombinant DNA technology. This process supports applications across diagnostics, therapeutics, research, and industrial biotechnology.</p>
  </section>

  <section class="container">
    <h2 class="svc-h2">Protein Expression</h2>
    <p>We provide multiple expression systems — mammalian, insect, bacterial, and yeast — each optimized to project-specific requirements.</p>

    <h3>Mammalian Expression</h3>
    <p>HEK293 and CHO suspension cultures enable large-scale recombinant protein and antibody production. Using plasmid transfection, BacMam viral transduction, or stable cell lines, we achieve high-yield and reproducible expression for intracellular, secreted, and membrane proteins.</p>

    <h3>Insect Expression</h3>
    <p>Baculovirus-mediated expression in insect cells supports scalable production of intracellular, secreted, or membrane proteins with mammalian-like post-translational modifications and fast turnaround.</p>

    <h3>Bacterial Expression</h3>
    <p><i>E. coli</i>-based systems offer reliable and reproducible protein expression at bioreactor scales up to 40 L per batch.</p>

    <h3>Yeast Expression</h3>
    <p>Yeast systems combine scalability with near-mammalian post-translational modifications, ideal for complex proteins. Genetic modification enables functional versions of therapeutically relevant proteins.</p>
  </section>

  <section class="container">
    <h2 class="svc-h2">Protein Purification</h2>
    <p>Protein purification isolates target proteins using physicochemical properties like size, charge, and hydrophobicity. Achieving &gt;90% purity ensures suitability for structural and functional studies.</p>
    <ul>
      <li>Sample Preparation</li>
      <li>Protein Extraction</li>
      <li>Optimization &amp; Purification</li>
      <li>Analysis &amp; Quality Control</li>
    </ul>
  </section>
</main>